Nexalin Technology Inc. has announced the appointment of Justin Van Fleet as its new Chief Financial Officer, effective August 1, 2025. Van Fleet brings over 20 years of experience in public accounting and assurance services, having most recently served as a Partner at Marcum LLP. As CFO, he will oversee Nexalin's financial strategy and reporting as the company advances its neurostimulation systems through regulatory review and commercial readiness.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.